@article{3ed8b041654d419185949f2e862129e8,
title = "Response",
author = "Frost, {Adaani E.}",
note = "Funding Information: Financial/nonfinancial disclosures: The author has reported to CHEST the following conflicts of interest: Dr Frost has participated in the steering committee of the REVEAL Registry since its inception and has been reimbursed for her time in the development of the database, modifications in the database, and direction of the scientific questions and data analysis. This registry is supported by a grant from Actelion Pharmaceuticals US, Inc. She is on the speakers' bureau and has received honoraria for speaking for several pulmonary hypertension-related pharmaceutical companies including Gilead, United Therapeutics, and Pfizer. She has also participated in and received honoraria for advisory boards for Bayer and Gilead. Baylor College of Medicine and Dr Frost as principal investigator have received funds for the conduct of institutional review board-approved multicenter national and international clinical research trials in pulmonary hypertension from Gilead, Pfizer, Lilly, United Therapeutics, Actelion, Novartis, and Bayer. She has also participated in advisory boards. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",
year = "2011",
month = sep,
day = "1",
doi = "10.1378/chest.11-0873",
language = "English (US)",
volume = "140",
pages = "829--830",
journal = "CHEST",
issn = "0012-3692",
publisher = "Elsevier",
number = "3",
}